Workplace Physical Activity Intervention

August 16, 2022 updated by: National Taiwan University Hospital

An Effectiveness Study of Workplace Physical Activity Intervention for Staff in a Hospital Setting

In this study, it investigates the effectiveness of workplace physical activity intervention for staff in a 100-bed hospital in Taipei City, Taiwan. The physical activity program takes group coaching and includes aerobic exercise, muscle strength and stretching in combination with nutrition education. The duration of the program is three months (8 sessions per month). The subjects of the study were recruited from full-time employees working at the hospital who attend the program. The recruited employees can take part in the program freely and chose types of activity by themselves. This study measures body mass index, muscle strength, body fat percentage, muscle strength, body mass index, daily energy expenditure, and exercise self-efficacy as the baseline. After 3-month program, we will evaluate the effectiveness of the program. The result is anticipated the greater frequent attendance, the more obvious effectiveness in outcomes.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

A three-month group coaching physical activity program in combination with nutrition education was developed for full-time employees working on a 100-bed hospital in Taipei City, Taiwan. Due to the setting that employees can take part in the program freely and chose types of activity by themselves. So participants may have various intensity of participation. This study aims to evaluate the effectiveness of pre- and post- 3-month workplace physical activity programs in body fat percentage, Muscle strength, body mass index, daily energy expenditure, and exercise self-efficacy. One group pretest-posttest design was used for the study by convenience sampling technique. Subjects were recruited from participants of the program. The intervention consists of : (1)education on nutrition: 2 times per month for 3 months, 1 hour/time ; and (2)physical activity: a three-month group coaching program (24 sessions), including three types of exercise courses such as aerobic exercise, muscle strength and stretching. All analyses were performed using Statistics Analysis System version 9.3 and the effects of the intervention were assessed by the paired t-test. Multiple regression analysis was used to determine the contribution of attendances of activities and behavior change stage to effectiveness of workplace physical activity. The level of significance was set at p < 0.05.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
86

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
      • Taipei, Taiwan
        • National Taiwan University Hospital
    • 新店區
      • Taipei City, 新店區, Taiwan, 231
        • National Taiwan University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

individuals who participate hospital self-developed workplace physical activity

Description

Inclusion Criteria:

  • full-time employees
  • Complete the informed consent

Exclusion Criteria:

  • With pacemaker
  • accepted or are participating participate other weight control related research or interventional medicine

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Change from Baseline Body fat percentage at 3 months
Time Frame: baseline, 3 month after intervention
Body fat percentage was the total mass of fat divided by total body mass, multiplied by 100. Estimate for body fat percentage was measured by dual frequency bio-electric impedance(BIA) body composition analyzer.
baseline, 3 month after intervention
Change from Baseline Muscle strength at 3 months
Time Frame: baseline, 3 month after intervention
Muscle strength was assessed by hand grip strength using a grip strength dynamometer. The grip strength dynamometer can measure range from 5 to 100 kg. During the measurement, the subject stood upright and was asked to hold the grip with the dynamometer with the greatest strength. Take the maximum value after two measurements.
baseline, 3 month after intervention
Change from Baseline exercise self-efficacy at 3 months
Time Frame: baseline, 3 month after intervention
The five-item self-efficacy questionnaire designed to measure confidence in one's ability to persist with exercising in various situations which included the following: tired, bad mood, don't have the time, on vacation, raining or snowing. An 7-point scale was used to rate each item of self-efficacy, scores range from 5 "not at all confident" to 35 "very confident". A score of 0 means "extremely low self-efficacy" and a score of 35 means" "extremely high self efficacy"
baseline, 3 month after intervention
Change from Baseline exercise behavior change stage at 3 months
Time Frame: baseline, 3 month after intervention
exercise behavior change stage
baseline, 3 month after intervention

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Change from Baseline body mass index at 3 months
Time Frame: baseline, 3 month after intervention
Body mass index (BMI) was calculated as body weight (kg) divided by the square of the body height (meter) (m2). BMI was assessed using a body composition analyzer.
baseline, 3 month after intervention
Change from Baseline Daily energy expenditure at 3 months
Time Frame: baseline, 3 month after intervention
Daily energy expenditure as an estimate of total kilo-calories of energy expended per day. Calculation from the seven-day physical activity recall questionnaire. Subjects were asked to list total activities in each category and quantifying the time spent (hour) in each activity over a seven-day period. Activities were classified by their energy requirements, expressed in terms of Metabolic Equivalent of Task (MET). Sleep = 1 MET; light activity = 1.0-2.9 MET (MET level: 1.5); moderate activity = 3.0-5.0 MET (MET level: 4); hard activity =5.1-6.9 MET (MET level: 6); very hard activity = 7.0 or greater MET (MET level: 10). Each activity's total kilo-calories of energy expended per day was calculated by the following equation: activity MET * times of having activity time(hours)*body weight(kg)/7 (day).
baseline, 3 month after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
National Taiwan University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 7, 2020

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
November 13, 2020

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
August 4, 2021

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
August 25, 2020

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 30, 2020

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
September 4, 2020

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 18, 2022

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 16, 2022

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 202007050RIND

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings